---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-000143"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-01-17T23:59:59+00:00"
generated_at: "2026-05-27T23:31:47.323120+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics prices ~$5M public offering of shares and warrants at $1.35/unit

## Summary
- Gross proceeds expected ~$5M; net proceeds ~$4.26M after placement agent fees and expenses.
- Offering includes 3,703,703 ordinary shares (or pre-funded warrants) and identical number of warrants exercisable at $1.35 for 5 years.
- Closing expected January 17, 2025; placement agent H.C. Wainwright & Co. receives 7% cash fee plus 1% management fee.
- Proceeds to advance pre-clinical studies for KRAS-driven cancer RNAi therapies and for general corporate purposes.

## SEC filing metadata
- accession: 0001178913-25-000143
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325000143/0001178913-25-000143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325000143/zk2532563.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-000143
- JSON: https://secwatch.observer/filing/0001178913-25-000143.json
- Plain text: https://secwatch.observer/filing/0001178913-25-000143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.